there were also significant differences in responses in , patients with malignant lymphoma compared to controls , against acidic and basic isoferritins in both tests , in lymphoma patients versus patients with other malignancies against acidic isoferritins in both tests , lymphoma versus other malignancy against basic isoferritins in the lmi test only .
C0024299
lymphoma
C0006826
malignancy